Incyte Corporation announced that it has scheduled its second quarter 2019 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 2019.
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter 2019 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 2019.
The schedule for the press release and conference call/webcast is as follows:
| • Q2 2019 Press Release: | July 30, 2019 at 7:00 a.m. ET | |
| • Q2 2019 Conference Call: | July 30, 2019 at 8:00 a.m. ET | |
| • Domestic Dial-In Number: | 877-407-3042 | |
| • International Dial-In Number: | 201-389-0864 | |
| • Conference ID Number: | 13692111 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13692111.
The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190711005001/en/
Contacts
Investors
Michael Booth, DPhil
+1 302 498 5914
mbooth@incyte.com
Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com
Source: Incyte Corporation
View this news release online at:
http://www.businesswire.com/news/home/20190711005001/en
